Showing results (41-50 of 82) with videos related to
Sort By:
Pageof 9
British Journal of Cancer|February 10, 2023
Head and neck cancer patient-derived tumouroid cultures: opportunities and challengesB W M Thilini J Basnayake, Paul Leo, Sudha Rao, et al.Pigment Cell & Melanoma Research|June 7, 2014
Real-time cell cycle imaging during melanoma growth, invasion, and drug responseNikolas K Haass, Kimberley A Beaumont, David S Hill, et al.Carcinogenesis|October 23, 2012
The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistanceDavid Wroblewski, Branka Mijatov, Nethia Mohana-Kumaran, et al.Cancer Medicine|February 23, 2019
Magnolol induces cell death through PI3K/Akt-mediated epigenetic modifications boosting treatment of BRAF- and NRAS-mutant melanomaAbdullah Al Emran, Brinda Reddy Chinna Chowdary, Farzana Ahmed, et al.Elife|November 29, 2021
Quantitative analysis of tumour spheroid structureAlexander P Browning, Jesse A Sharp, Ryan J Murphy, et al.Journal of Cell Science|July 14, 2018
FGFR2-activating mutations disrupt cell polarity to potentiate migration and invasion in endometrial cancer cell modelsSamantha J Stehbens, Robert J Ju, Mark N Adams, et al.The Journal of Steroid Biochemistry and Molecular Biology|January 16, 2022
PTEN: A novel target for vitamin D in melanomaArtur Shariev, Nicole Painter, Vivienne E Reeve, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when combined with docetaxelNikolas K Haass, Katrin Sproesser, Thiennga K Nguyen, et al.Translational Psychiatry|December 18, 2024
The clinically relevant MEK inhibitor mirdametinib combined with D-cycloserine and prediction error disrupts fear memory in PTSD modelsSanket B Raut, Fanny Joly, Nikolas K Haass, et al.The Journal of Investigative Dermatology|March 13, 2016
Cell Cycle Phase-Specific Drug Resistance as an Escape Mechanism of Melanoma CellsKimberley A Beaumont, David S Hill, Sheena M Daignault, et al.Pageof 9